Dr Sherwin’s scientific background is in biochemistry with an emphasis on osteoarthritis, tissue engineering and cell culture. She has wide experience in both cell and molecular biology techniques. Dr Sherwin has excellent writing skills and has published several peer-reviewed journal articles and scientific reports as both lead author and supporting author during her post-doctoral work in the United Kingdom and New Zealand. Dr Sherwin has been a full-time editor with Edanz Editing since 2002. During that time, she has edited over 3000 manuscripts in the Health and Life Sciences for Japanese and Chinese authors, with a wide range of research fields and target journals.

Dr Cummins teaches Anatomy, Human Biology and Reproductive Biotechnology at Murdoch University in Western Australia. He has extensive experience in reproductive biology and assisted conception techniques such as in vitro fertilization (IVF). He sits on the editorial board of several top journals, including Human Reproduction and Reproductive Biotechnology Online, and chairs the Scientific Advisory Committee of the Reproductive Technology Council of Western Australia (the government body overseeing IVF clinics). He has been involved in professional editing for 10 years and has worked on about 2500 papers. He has many colleagues and friends in Asia and was a Visiting Professor at Osaka University's Genome Information Research Center in Japan in 2005. Assoc Prof Cummins began editing for the Edanz Group in 2009.

Dr Fee is a professor of chemical engineering at the University of Canterbury, with expertise particularly in biotechnology, biochemical and biomolecular engineering. His PhD topic was on blood flow disturbances in the carotid artery and their links to atherosclerosis. He was a post-doctoral fellow at the University of Waterloo, Canada, in 1989/90, working on membrane ultrafiltration. He then returned to NZ as a lecturer at the University of Waikato, and a biochemical engineer at the Meat Industry Research Institute of New Zealand (MIRINZ). A full-time lecturer at the University of Waikato from 1996, he was head of the Department of Materials and Process Engineering from 2003 until 2006, when he took up a chair in chemical engineering at the University of Canterbury. Dr Fee has a wide range of experience in protein purification, protein PEGylation, membrane separations and process chromatography, and has worked in controlled drug delivery, microencapsulation and high-value dairy protein purifications. He is Director of the Biomolecular Interactions Centre at the University of Canterbury and has expertise in surface plasmon resonance. Dr Fee has published over 160 journal articles, book chapters, conference papers, patents and industrial research reports across a wide range of chemical engineering topics. Dr Fee began working with Edanz Editing as an editor in fields associated with chemical engineering and biotechnology in 2008.

Dr Curtis’s PhD thesis was entitled “Neural Progenitor Cells in Huntington’s Disease Human Brain.” He is currently a Post-doctoral Research Fellow studying neurodegenerative disorders. Dr Curtis has authored many published reports in several leading international journals including the cover article for an issue of Science in 2007. He has given invited lectures in several countries, presenting topics associated with the field of neurology. Dr Curtis began editing for Edanz Editing in early 2006 and works in a very broad area of the biomedical sciences, applying his extensive knowledge of laboratory and imaging procedures.

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.

Dr Wright has been editing scientific manuscripts for non-native authors since 1997 and has been an editor for Edanz Editing since 2004. His scientific background is diverse, with the main scientific fields being in chemistry (organic, organometallic, inorganic and surface), semiconductors, biosensors (transducers, DNA and protein arrays) and nanotechnology. In 1996/7, Dr Wright was a Post-doctoral Fellow at The University of Tokyo, Japan, investigating novel catalytic pathways capable of generating ammonia under milder conditions than presently used in industry. As well as working for Edanz Editing, Dr Wright, now based in the UK, continues as a research scientist in the field of bionanosensors.

Dr McGowan has won many awards during his career, including in 2003 the EU Marie Curie Post-doctoral Fellowship. He has worked in laboratories investigating the molecular mechanisms in Parkinson’s disease as well as those involved in Huntington’s disease, combining laser micro-dissection, microarray analysis and proteomics. Further study involved micro-array gene expression analysis of molecular processes occurring during normal aging and how these are affected by mental exercise. Dr McGowan has an in-depth knowledge of neurodegenerative diseases, neural function, marine zoology, molecular and cellular biology and protein biochemistry, along with extensive multi-disciplinary laboratory experience of contemporary and traditional techniques including proteomics, functional genomics and cell imaging. His excellent written and oral communication skills are demonstrated by several first author publications. From 2005 to October 2006, Dr McGowan was an Associate Editor at Nature Reviews Neuroscience before becoming a full-time editor for Edanz Editing. Dr McGowan is the Edanz Group Science Director.

Dr Allen is a biologist with particular experience in the fields of neuroscience, developmental biology and genetics. His PhD topic involved molecular genetic analysis of mouse mutations that affect limb development. From 1996 to 2004, Dr Allen was a researcher at the Department of Neurobiology, Babraham Institute, Cambridge, UK. Dr Allen’s research skills and techniques include DNA/RNA manipulation and purification/isolation, electrophoreses, PCR, cloning, all blottings, library screening, genetic mapping, design and construction of transgenes, artificial chromosome engineering, design and construction of vectors for gene targeting in ES cells, cell culture, histological techniques, mouse behavioral analysis, small animal surgery, and bioinformatic tools such as sequence databases and analysis tools. Dr Allen began working with Edanz Editing as an editor in fields associated with neuroscience and genetics in 2007.

Dr Fox completed a PhD in microbiology at the University of Oxford, investigating novel phase variable LPS biosynthetic genes in Haemophilus influenzae. She then spent five years as a post-doctoral researcher at the University of Queensland, Australia, focusing on the role of DNA methyltransferases in gene regulation in bacterial pathogens. Other projects included the design and development of live, attenuated vaccines for veterinary pathogens. She has many first-author publications in high-ranking journals in the area of microbial pathogenesis. Dr Fox is now a full-time editor, with extensive editing experience in a broad range of biological disciplines including molecular biology, microbiology, biotechnology, genomics, epidemiology, biochemistry and medicine. Dr Fox began editing with the Edanz Group in 2009.

For 10 years, Dr Stewart was a Post-Doctoral Research Scientist at Edinburgh and Glasgow Universities, involved in molecular biology research that included sequencing and analysis of various genes for genome projects. Dr Stewart is an experienced bioinformatics analyst with specific experience in DNA/protein sequence data. From 2001 to 2007, Dr Stewart was a Senior Analyst in Thomson Scientific’s GENESEQ team based in Glasgow. Dr Stewart began as an editor for Edanz Editing in 2007, working in molecular biology fields with an emphasis on genomics.

Dr Eager currently practices internal medicine as a hospitalist in Dallas, Texas, USA. Over the past decade he has amassed considerable experience in clinical and pre-clinical research, principally in the field of oncology. He was a member of the Mary Crowley Cancer Research Center Institutional Review Board for six years, during which time he reviewed numerous Phase I through Phase III clinical protocols. In addition to his clinical expertise, Dr Eager has experience with in-vitro pre-clinical protocols and techniques as well as cell culture, histological methods, and animal model studies, and is skilled in a wide range of microbiology techniques. Dr Eager has authored and co-authored eight publications, and has authored four clinical or pre-clinical protocols. On a part-time basis, Dr Eager has edited scientific manuscripts professionally for the past year and began editing for the Edanz Group in 2011.

Dr Dingley’s research is broadly in the area of biochemistry, with particular interest in characterizing protein structure and function. Dr Dingley has over 15 years' experience in publishing articles in international high-impact journals. He has written scientific book chapters, and is an editor on the editorial advisory board for the Biochemical Journal. Dr Dingley began as an editor for Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

Dr Lodge is a cell biologist with wide-ranging experience in academic research, early stage drug discovery, and stem cell therapy regulatory affairs. For his PhD and postdoctoral work, Dr Lodge studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr Lodge joined GlaxoSmithKline in 2001, where he held research and programme leadership roles within target validation initiatives for neurodegenerative and psychiatric diseases. He was also involved in developing drug discovery strategies involving stem cells. From 2009 to 2011, Dr Lodge was Programme Manager for a stem cell therapy unit at University College London, where he was responsible for the unit obtaining the necessary licenses required by the recently introduced Advanced Therapy Medicinal Products (ATMPs) directive. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques, including their application to drug discovery assay development. Dr Lodge has published several first author publications in international peer-reviewed journals, and he is experienced in writing a variety of pre-clinical and clinical regulatory documents. Dr Lodge currently offers consulting services in cell-based drug discovery, ATMP regulatory affairs, and scientific writing (including web development). He began editing for the Edanz Group in 2008.

Dr Jefferies has extensive research experience in molecular parasitology with a particular interest in emerging infectious diseases. He is currently working as a research scientist at the University of Bristol, UK, in the Schools of Biological Sciences and Veterinary Science. Dr Jefferies has published more than 20 research papers and is a reviewer for multiple journals in the fields of parasitology and veterinary science. With experience in both academic and commercial research environments, Dr Jefferies has expertise in the development of novel diagnostic methods, molecular epidemiology, population genetics, phylogenetics, molecular taxonomy and protein characterization. He has also worked on peptide-based drug discovery using yeast two-hybrid systems. Dr Jefferies began working with the Edanz Group as an editor in 2010.

Warren Raye graduated from Murdoch University in 2005 with a PhD in Veterinary Virology. His doctoral thesis was entitled "An investigation into the status of porcine circovirus in Australia". Dr Raye is an experienced researcher and lecturer, at undergraduate and post-graduate levels. He was formerly employed by Monash University as a Research Fellow and Lecturer in the fast-changing field of stem cell biology. Dr Raye has also conducted independent research in the areas of molecular virology, inflammation biology and molecular biology. His former work at Monash University involved creating embryonic stem cell lines with various reporter systems for use in small molecule drug screening assays. Other skills and techniques he possesses include mammalian and insect cell culture; growth and differentiation of embryonic stem cell cultures; purification of viruses; PCR; cloning; DNA sequencing and analysis; DNA/RNA manipulation and isolation; expression and purification of recombinant proteins in prokaryotic and eukaryotic systems; electrophoresis; development and optimization of ELISAs; design and construction of recombinant viruses for eukaryotic protein expression; in situ hybridization; monoclonal antibody production; and live cell calcium imaging. Dr Raye began working as an editor with the Edanz Group in early 2009, before moving to Fukuoka and taking up the position of Senior Life Sciences Editor in November 2010. As well as editing, Dr Raye also gives training and education seminars for non-native speaking authors to improve their manuscript writing.

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

Dr Davies is a biologist with particular expertise in the areas of neuroscience, oncology, and chromatin structure and gene expression. Dr Davies has held Postdoctoral Fellow positions at a number of institutes including the François Magendie Institute for Neuroscience, Bordeaux, France, and the Children’s Cancer Institute Australia. During his PhD, he examined chromatin structure and cisplatin damage at the human beta-globin gene cluster. Dr Davies has been a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. He has a number of first-author publications in journals such as Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics. Dr Davies has experience in a wide variety of laboratory techniques, including acute and organotypic culture, adenovirus manipulation, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, fluorescent and confocal microscopy, cell microinjection, in vivo mouse models, western blot, electrophoretic gel mobility shift assay, PCR (most varieties), cloning and bacterial plasmid production. Dr Davies began working as an editor for Edanz Editing in 2006.

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Desport is a molecular virologist with interests in animal health. Her thesis for her PhD in Veterinary Virology from the Royal Veterinary College was entitled “Genomic Variation and Cell Tropism of Bovine Viral Diarrhea Virus”. Dr Desport post-doctoral position at Murdoch University focused on the development and testing of a recombinant protein vaccine to control Jembrana disease in Bali cattle. Skills and techniques include cell culture and purification of viruses; Real-Time RT/PCR; cloning; DNA sequencing and analysis; DNA/RNA manipulation and isolation; expression and purification of recombinant proteins in prokaryotic systems; development and optimization of ELISAs; in situ hybridization; immunostaining; histopathology and peptide mapping. Dr Desport has published eight first-author journal articles and has presented at several national and international conferences. She is an invited reviewer for a number of international journals and has recently edited a book entitled “Lentiviruses and Macrophages: Molecular and Cellular Interactions”. Dr Desport joined the Edanz Group as an editor in 2011.

Dr Yajima's background is in proteomics, molecular biology, and plant pathology. He is the first author of numerous manuscripts published in peer-reviewed scientific journals. Additionally, he is a co-author of a book chapter, an online encyclopedia chapter, an online technical guide/magazine, and an extensive review article. Prior to joining Edanz, he gained experience in editing/proofreading through freelance work. He has also served as a reviewer for international scientific journals. Dr Yajima joined the Edanz Group as a Senior Editor in the Fukuoka office in November 2011.

Dr Sharman's PhD, in the lab of Peter Holland, focused on homeobox gene duplication in early vertebrate evolution. Her post-doctoral work was with Michael Brand on zebrafish neural development; during which she published three first-author papers and three reviews. Dr Sharman then moved into journal editing. She was Editor of Trends in Biochemical Sciences, Assistant Editor of Current Biology and then Senior Editor of Genome Biology. With seven years experience as an in-house journal editor Dr Sharman understands journal publishing and what peer reviewers require in a manuscript. Dr Sharman attained Advanced Member status of the Society for Editors and Proofreaders in 2010 and edits in all areas of biology and medicine; particularly manuscripts on evolution, developmental biology and genomics. Dr Sharman began editing for the Edanz Group in 2011.

Dr Nana's PhD research focused on the pattern of cell loss in the human cerebral cortex in Huntington's disease. Dr Nana has experience in human tissue studies with skills in human brain banking, cellular studies of human tissue (histology and immunohistochemistry), molecular biology (western blotting and in-situ hybridization), microscopy (brightfield, fluorescence and confocal) and quantitative analysis (stereology and morphometric analyses). Her research focus is neurodegeneration and she is currently a post-doctoral research fellow. Dr Nana has published in peer-reviewed journals and has presented at many international conferences. She joined the Edanz Group as an editor in 2011.

Dr March is a cancer biologist with special interests in cell signaling and intestinal oncology. Her PhD research examined the regulation of AP-1 proteins by MAP kinase pathways. Dr March is currently a Senior Postdoctoral Research Fellow at the Cancer Research UK Cambridge Research Institute, where her work focuses on the application of innovative models to identify and characterize novel driver genes in colorectal cancer. Previously, Dr March was a Postdoctoral Research Scientist at the Babraham Institute, UK, where, in collaboration with UCB Pharma, she studied the mode of action of an anti-epilepsy drug. She also has experience working in the biotechnology industry. Dr March has given invited lectures both nationally and internationally, and has published in several international peer-reviewed journals. Dr March joined Edanz as an editor in early 2011.

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

Dr Lutze's graduate work was in vision science. Her studies involved the assessment of changes in color vision with disease and the genetic basis of color vision. She worked alongside ophthalmologists during post-doctoral training and has experience with ophthalmological clinical activities and research. She later worked with an ophthalmologist studying diabetic retinopathy and other retinal diseases. Dr Lutze works as a language editor for a gastroenterology journal based in Beijing, China, and began working as an editor with the Edanz Group in 2009.

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Dr Biswas is a bioinformatics scientist with experience in DNA/protein database annotation, sequence analysis and molecular modeling. For seven years Dr Biswas was a Post-Doctoral Research Associate using molecular modeling techniques to study protein-ligand binding. She then joined the newly formed Bioinformatics Centre at the Indian Institute of Science as a Senior Scientific Officer responsible for the development of training courses and research projects. Dr Biswas returned to the UK in 1998 as a Database Curator at the European Bioinformatics Institute, Cambridge, where she was involved in database production, annotation and research. From 2002 to 2009, Dr Biswas worked as a Bioinformatics Scientist for a private company in New Zealand. She worked in a range of projects aimed at understanding how genes and other factors interact to influence complex biological traits in animals and plants. Dr Biswas, a Scottish-born native speaker of English, has extensive writing and publication experience. She has published 24 papers in international peer-reviewed journals and has co-authored scientific book chapters. Dr Biswas began editing for the Edanz Group in 2010.

Dr Finnie is a stem cell biologist whose PhD research led to the identification and isolation of rare stem cell populations within umbilical cord blood, with the potential for bone and cartilage tissue engineering applications. Dr Finnie was then a senior Postdoctoral Research Scientist at Smith & Nephew's research center in the UK, where she worked at the forefront of both research and development stages to commercialize adult stem cell therapies for regenerative medicine, namely bone replacement and Osteoarthritis. Dr Finnie has published her research in international peer-reviewed journals. She is currently a science writer and editor across diverse biological areas and is a member of the European Medical Writers Association (EMWA). Dr Finnie joined Edanz as an editor in November 2011.

Dr Roberts has experience in a wide range of research fields. His PhD research focused on measuring effective charges in nonaqueous colloidal systems using optical tweezers in combination with an electrophoretic cell. After completing his PhD, he worked for two years as a postdoctoral research fellow at the AIBN, in the University of Queensland in Brisbane, Australia. His research used tunable nanopores to detect the biomodification of nanoparticles, aiming to develop a simple, easily applied bioassay technique. Dr Roberts is currently a postdoctoral research fellow in the Materials Science Research Centre at Chiang Mai University, Thailand. He works in the area of nanotechnology attempting to create stronger carbon nanotube networks. Dr Roberts joined the Edanz Group as an editor in 2011.

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr Devenish's current research examines the role of quaternary structure in enzyme function. His PhD was obtained in organic chemistry, in the field of natural products isolation and hemisynthesis, and also involved significant amounts of peptide synthesis as well as polymer chemistry. Dr Devenish’s recent research has been in the field of enzymology, where he has worked on biochemical and biophysical characterization of enzymes, molecular cloning techniques and site-directed mutagenesis. Dr Devenish continues in active research, and has a successful publication record. Dr Devenish started working with the Edanz Group in 2009.

Dr Dean’s PhD thesis was titled “Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury.” Dr Dean is presently a post-doctoral research fellow in fields related to neuroscience. He has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem and dissections, as well as in stereotaxic placement of microdialysis and laser Doppler probes. In electrophysiology, Dr Dean is skilled in the instrumentation, recording, and analysis of electrophysiological data in vivo, including cortical EEG spike wave and seizure activity, cerebral impedance, cerebral near-infrared spectroscopy (NIRS), cerebral laser Doppler, temperature, ECG, EMG, blood pressure, ultrasonic blood flow measurement, and fetal breathing movements. He possesses training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. In molecular fields, Dr Dean covers the various blot analysis techniques, primer design and sequence analysis, mRNA and protein extractions, RT-PCR and gel electrophoresis. Histology including staining and analysis of brain tissue and imaging and the associated laboratory skills are all areas in which Dr Dean has experience. Dr Dean began as an editor for Edanz Editing in 2007, and works in fields related to chemistry and neuroscience.

Ms Weidow is a freelance scientific and medical editor with over 6 years experience as a writer and editor in academia, healthcare, and industry. Ms Weidow has degrees in microbiology, statistics, and English from The University of Tennessee, with additional training in scientific writing at Vanderbilt University. She did her thesis research in a multidisciplinary cancer biology laboratory, where she designed small peptide therapeutics for the adjuvant treatment of some cancers. She has worked in academic laboratories for many years, and has contributed in various capacities (writing, editing, data analysis) to hundreds of peer-reviewed journal articles, book chapters, funded grant proposals, patents, abstracts, posters, standard operating procedures, media releases, and many other types of technical literature. Ms Weidow is a member of the Council of Science Editors, the American Medical Writers Association, and the Society for Scholarly Publishing. She edits and writes in a wide range of subject areas – most notably microbiology, cancer biology, oncology, cell biology, matrix biology, bioengineering, immunology, biostatistics, and method development. She began working as an editor with the Edanz Group in 2010.

Dr Williams’ PhD investigated the role of non-viral delivery in gene therapy. She then spent three years working as a postdoctoral researcher on the gene regulation of cystic fibrosis. Dr Williams’ main areas of expertise are genetics, cell biology, molecular biology, biochemistry, plant sciences, medicine, surgery, microbiology and biotechnology. Dr Williams has published several first-author articles in peer-ranking journals and presented her work at international conferences. She has also been a finalist in the (UK) Young Science Writer of the Year award with a report on the role of a speech and language gene in the evolution of humans. Dr Williams joined the Edanz Group as an editor in 2012.

Dr Benyon is a researcher for the USDA-ARS in the US Horticultural Research Laboratory, which concentrates on improving citrus and specialty crops. His current research involves identifying genetic targets for combating Huanglongbing/Citrus greening in citrus, the bacterial pathogen, and the insect vectors. Dr Benyon has a diversified science background, including having researched antimicrobial peptides at the Howard Hughes Medical Institute. Dr Benyon has also worked in East Asia with scientists from Fujian Agriculture and Forestry University, China, and was a post-doctoral associate at Okayama University in Japan. Dr Benyon began editing for the Edanz Group in 2011.

Dr Zahn has 30 years’ experience as a researcher in academia and the biotechnology industry, with expertise in the molecular genetics and biotechnological applications of bacteriophage, bacteria, yeast and fungi. After completing a PhD in the laboratory of Dr Frederick Blattner, he was a postdoctoral fellow at Brown University with Dr Arthur Landy, and then a Sackler Fellow in Molecular Genetics and Informatics with Dr Joshua Lederberg at Rockefeller University. Dr Zahn has also worked as a NEDO Industrial Technology Fellow in the Molecular Microbiology Group at RITE, Kyoto, Japan with Dr Hideaki Yukawa. He currently works in the biotechnology industry in the San Francisco Area. Dr Zahn began working as an editor with the Edanz Group in 2010.

For his PhD, Dr Wilhelmi researched the bioremediation of heavy metals from contaminated mine waste waters. He then worked in a doping control Research and Development laboratory investigating immunological techniques for the detection of corticosteroids. On returning to academia his research has been in a number of biochemical fields, including P450 drug metabolism, DNA barcoding, continuous fermentation and bioremediation. His current research involves the isolation of liver microsomes, cloning, expression and characterization of P450 isoforms. This research is aimed at determining the metabolism of various novel compounds and drugs of abuse. A second research interest investigates the potential of using DNA markers for determining the diet of elusive and dangerous herbivores on South African game reserves. In particular the work has investigated the rbcL gene as a biomarker for plants consumed by these herbivores. Dr Wilhelmi is a senior lecturer at Rhodes University, where he teaches metabolism, analytical techniques and forensic biochemistry. He has presented at conferences and has published in the areas of chromatography and analytical biochemistry, conservation biochemistry, and enzymology. Dr Wilhelmi joined the Edanz Group as an editor in 2012.

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011

Prof Mackraj is an Associate Professor in the Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of Kwazulu-Natal. She teaches Human Physiology and Human Genetics at the Faculty of Health Sciences and the Nelson R Mandela School of Medicine. She is responsible for running a gene expression laboratory. Her main research focuses are hypertension and its management using medicinal plants; and the etiology and treatment of pre-eclampsia. Prof Mackraj’s postdoctoral work involved the generation and characterization of a gene-disrupted proximal tubular cell model for the investigation of transporter mechanisms in the kidney. Her current research projects involve the investigation of blood pressure lowering plants with a focus on the renin-angiotensin system; and the etiopathology of pre-eclampsia in the local population. She is also a participant in projects involving novel drug delivery systems. She is a well-published author in ISI-listed journals, and is the Principle grant-holder for her research projects. Prof Mackraj joined the Edanz Group as an editor and reviewer in 2011

Dr Barnett's PhD thesis, "Effect of variation in maternal protein intake during gestation and lactation on fuel metabolism in the offspring - studies in the rat", investigated the effects of early nutrition on pancreatic function and insulin metabolism. Dr Barnett post-doctoral studies investigated the role of omega-3 and omega-6 fatty acids on intestinal inflammation in a mouse model using 'omics' technologies such as microarrays and proteomics. He is currently a Senior Research Scientist working for AgResearch in New Zealand; recently working in the field of epigenetics, in particular DNA methylation. Dr Barnett has published 20 peer-reviewed journal articles (11 since 2010) and one peer-reviewed book chapter, and has been an invited speaker at a number of international conferences. Dr Barnett joined the Edanz Group as an editor in 2011 with editing expertise in physiology, genomics/proteomics/metabolomics, epigenetics and intestinal inflammation and immunity.

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011

Dr Fayle’s PhD focused on Food Chemistry. Her postdoctoral research was done in the Department of Food and Nutrition at the University of Reading, UK. She then worked as a scientist for Crop and Food Research in New Zealand. Dr Fayle’s laboratory skills include both traditional gel electrophoresis and capillary electrophoresis techniques, HPLC, organic synthesis, protein purification and identification, and NMR. Dr Fayle has expert knowledge of the Maillard Reaction, and is the author of a Royal Society of Chemistry monograph on this reaction. She also has authored twenty related publications, and has been an invited speaker at international conferences in her field of study. She began working with the Edanz Group as an editor in 2010.

Dr Alan Robinson is a senior process chemist working in the agricultural industry. His work requires a deep understanding across a wide range of chemical fields. He has extensive experience in organic and physical organic chemistry, especially with respect to synthesis, mechanism and kinetics. Dr Robinson completed his PhD, based on the development and understanding of new catalysts for diene and enyne metathesis, with internationally acclaimed Prof Lloyd-Jones in 2005. He has spoken and presented prize winning posters at numerous symposia, and recently co-authored an important paper in Chemistry – A European Journal. Dr Robinson began working with the Edanz Group as an editor in 2010.

Dr Walmsley recently completed her PhD in Molecular Marine Microbiology and Natural Product Chemistry. Her research, entitled “Investigating the link between microbial diversity and secondary metabolite production in endemic South African marine sponges of the genus Tsitsikamma” instigated the establishment of an environmental genomics project at Rhodes University. Dr Walmsley has extensive experience in molecular microbiology and natural product chemistry, including techniques such as cloning, Sanger sequencing, 454 pyrosequencing, phylogenetics, genetic identification, isolation of pure cultures, fermentation, natural product isolation and identification, nuclear magnetic resonance, denaturing gradient gel electrophoresis, sequence analysis and interpretation, polymerase chain reaction, DNA isolation, scanning electron microscopy, high pressure liquid chromatography, large scale column chromatography, media preparation and sterile techniques. Dr Walmsley joined the Edanz Group as an editor in 2011.

Dr Burns was a staff scientist at Sandia National Laboratories in Albuquerque, New Mexico, USA, for 31 years. His career began with gas phase laser spectroscopy with applications to quantum-resolved detection of molecules desorbed from transition metal surfaces. After many years of research in the field of desorption induced by electronic transitions, he began to focus on interfacial tribology and investigated the molecular-level aspects of friction with novel scanning probe techniques and conjugated polymer interfaces. During his final years of active research, he collaborated with the Dept. of Pathology at the University of New Mexico on the structural characterization of signaling domains in cellular membranes using combined atomic force microscopy and fluorescence imaging. Dr Burns joined the Edanz Group as an editor in 2011.

Dr Byrne’s PhD studies in neuroanatomy and neuropharmacology have centered on the role of oxidative stress in neurodegenerative diseases. In her research she investigated the expression and activity of the pro-oxidant enzyme, myeloperoxidase, in post-mortem human brain tissue and in cellular models of neurofibrillary pathology. She has published two papers in international peer-reviewed journals and is currently a teaching fellow in human biology at the University of Otago, New Zealand. She began working as an editor for the Edanz Group in 2010.

Dr Jackson’s PhD investigated bone healing mechanisms, focusing on mechanical loading and growth factors as healing agents, as well as fracture repair strategies. Her earlier studies had a strong focus toward human anatomy, physiology and forensic osteology. For five years Dr Jackson was a post-doctoral research fellow at the Institute of Molecular and Cell Biology in Singapore, where she also acted as an in-house scientific editor. Her postdoctoral research explored protein-protein interactions within signal transduction cascades, and the role of particular tumor-suppressor genes in breast cancer and mammary gland development. Dr Jackson has published 13 papers in peer-reviewed journals and has 16 conference papers. Dr Jackson also has a certificate in Professional Editing and Proofreading, and began editing for the Edanz Group in 2010.

After graduation from Cornell University, Mr Milazzo worked for 10 years at a preclinical contract research organization where he was in charge of multi-disciplinary programs for biotechnology, pharmaceutical and medical device companies. Later Mr Milazzo became the director of preclinical research for a biotechnology company developing controlled-release drug implants for ophthalmic, orthopedic, and cardiovascular use, contributing to several IND and NDA applications to the US FDA. Mr Milazzo moved to New Zealand for his PhD studies, and has been working with biotechnology companies developing peptide therapies for muscle wasting disease and molecular diagnostic products for cancer detection and monitoring. His PhD thesis submitted in 2010, was entitled "Sheep Fat Bingo - A Comparison of Subcutaneous Adipose-Derived Mesenchymal Stem Cells with Infrapatellar Adipose-Derived Mesenchymal Stem Cells with Regard to their Chondrogenic Ability in a Sheep Model of Osteochondral Defect Repair". Mr Milazzo’s laboratory expertise includes techniques and surgical skills (particularly orthopedic) associated with a variety of large and small research animal models. These include stem cell and chondrocyte isolation and culture, immunohistochemistry, biochemical assay, histopathology specimen preparation and evaluation, microscopy, RNA extraction and cDNA preparation, and gene microarray. Mr Milazzo joined the Edanz Group as an editor in 2011.

Dr Sheen is a postdoctoral research fellow at San Diego State University, studying microbial pathogenesis. Her work encompasses microbial niche establishment as well as penetration of the blood-brain barrier. She also has two patents for the development of novel therapeutic agents for treatment of MRSA infections. Dr Sheen carried out her PhD research at AgResearch in Lincoln, New Zealand, focusing on applying genetic techniques to improve the soil survival of a microbial biocontrol agent. Her other research has involved the phylogenetic analysis of Antarctic notothenioid fish and species evolution. Dr Sheen began editing for Edanz Editing in 2011.

Ms Igelstrom currently works as an electrophysiologist at the University of Otago. She has a background in biochemistry and physiology, and is now specializing in neuroscience. Her PhD research focused on brain slice models of epileptic seizures, and she is currently investigating ion channel modulators for antiepileptic drug treatment. She has experience with a variety of electrophysiological techniques, including whole-cell voltage/current clamp, cell-attached tight-seal current clamp, field potential recording, and single-unit recording. Her past and current research interests include behavioral reward conditioning, olfactory processing, non-synaptic neurotransmission, epileptic seizures, antiepileptic drugs, and antidepressant drugs. Ms Igelstrom also has a special interest in the physiological effects of alternative and complementary therapies, such as Chinese medicine and yoga. Apart from her electrophysiological skills, Ms Igelstrom also has experience with cell culture, western blotting, microscopy, behavioral rat training, and immunohistochemistry. Ms Igelstrom joined the Edanz Group as an editor in 2011.

Dr Kam’s PhD studies focused on the identification and characterization of neural stem cells in the adult human brain. Her thesis entitled ‘The rostral migratory stream in the normal adult human brain’ and her other studies have resulted in several journal publications including an article in Science in 2007. Currently, Dr Kam is a senior tutor in the Department of Physiology, University of Auckland. She began working as an editor for the Edanz Group in 2011.

Dr Schade-Bijur’s PhD focused on identifying the promoter region of a neuronal sodium channel in the human brain. Dr Schade-Bijur’s work from these studies has been presented at an international Society of Neuroscience meeting and published in peer-reviewed journals. She is highly skilled in molecular biology techniques, such as cloning, mRNA, DNA and protein extraction, RT-PCR, blotting, sequencing and gel electrophoresis. For seven years Dr Schade-Bijur worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology. As a scientist and the Senior Manager for Manufacturing, Dr Schade-Bijur performed histology experiments for various tissues, including using a microtome for tissue slice preparation, and oocyte extraction and electrophysiology on a glioma chloride channel. Dr Schade-Bijur was also in charge of the clinical pharmacy and was part of the clinical team writing grants and regulatory documents. From this research she published two more peer-reviewed papers, including a clinical trial paper. As a freelance writer, Dr Schade-Bijur has written in the areas of health economics, medical education regarding cancer angiogenesis and over 50 technical bulletins about lipid products. Dr Schade-Bijur has a particularly broad science and writing background. She joined the Edanz Group as a writer and editor in 2010, specializing in the fields of neuroscience and oncology.

Dr Colton's research background in biochemistry focused on lipid biochemical pathways in marine invertebrates and mammalian skin. His doctoral thesis involved describing the biochemical pathways for sebaceous lipid production in the genus Equus through radio-label, structural analysis, and comparative biochemical studies. His post-doctoral work involved relating the giant ring lactones of equine sebum to the epidermal water barrier of mammalian skin. Dr Colton is a generalist scientist and, as a college professor, taught courses from inorganic and organic chemistry to biochemistry and molecular biology to nuclear physics and astronomy. He has advised and edited numerous theses, papers, and articles for colleagues and students. He has published 13 papers in peer-reviewed journals and has been an active editor since 2007. Dr Colton began editing for the Edanz Group in 2009.

Dr Hitchin is a synthetic organic chemist with over eight years of experience in the pharmaceutical and fine chemical industries. He is skilled in the areas of synthetic chemistry, medicinal chemistry and process research and development. Dr Hitchin's PhD investigated the synthesis and application of poly-functionalized quinuclidine systems. He is currently a Senior Scientific Officer for Cancer Research UK at the Paterson Institute of Cancer Research in the UK, where he leads a team of medicinal chemists investigating novel drug discovery targets in oncology. Dr Hitchin has also worked as a Chemistry Group Leader for Pfizer Global Research and Development at the Sandwich laboratories in Kent, UK, where he was responsible for the successful design and implementation of synthetic strategies across therapeutic areas including pain, obesity and virology. Further to this, Dr Hitchin has worked providing c-GMP manufacture in an FDA approved facility. Dr Hitchin has published in several peer-reviewed journals. He joined the Edanz Group as an editor in 2011.

Dr Ao completed her PhD studies in Biochemistry and Molecular Biology, with a focus on cancer biology and anti-estrogen therapy resistance. She is currently a postdoctoral fellow at Vanderbilt University, conducting research in the interdisciplinary field of regenerative chemical biology. She has composed and published a number of peer-reviewed articles, a review article, and a book chapter for a broader scientific audience. The topics ranged from the influence of epigenetics on cancer biology, chemical biology in regenerative medicine, and the role of cancer stem cells in anti-estrogen therapy resistance. Dr Ao joined the Edanz Group as an editor in 2011.

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

Dr Price's training is as a pharmacologist, with specific emphasis on molecular pharmacology, signal transduction, and neuroscience. His research includes extensive work on immunophilins, a class of compounds that promote nerve regeneration. He has worked in both pharmaceutical and small biotechnology companies in Japan, the US, and Europe. He has published over 20 research articles, including an invited review. Over the past seven years, Dr Price has edited/co-written over 1100 scientific publications, presentations, and regulatory documents. Dr Price began as an editor with the Edanz Group in 2008.

Mr Dods has a broad scientific and international background having worked in China and Japan on projects of characterizing rubber compounds with the Yokohama Rubber Company in Hiratsuka, Japan and developing certified reference materials for environmental analysis with the National Institute of Advanced Industrial Science and Technology in Tsukuba, Japan. Currently, he is a postgraduate researcher investigating electrospun nanofibers for bioprocessing as part of a collaboration between the Advanced Centre of Biochemical Engineering at the University College London, and the Micro and Nanotechnology Centre of the Science and Technology Facilities Council, Didcot, UK. The aim is to develop affinity chromatography membranes for purification in the downstream processing of biomolecules by chemical functionalizing nanofiber mats and allowing ion exchange groups, protein or enzyme immobilization. Relevant applications are in tissue engineering and drug release matrices. Mr Dods joined the Edanz Group in 2009, working for a year as an in-house editor based in Beijing before returning to the UK.

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts; as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Dr Mündermann’s scientific background is biomechanics with an emphasis on degenerative joint disease and joint loading. For her PhD, she investigated mechanics of running with different types of foot orthoses and received the Chancellors' Gold Medal for her dissertation. As a Post-doctoral Fellow at Stanford University, she focused on mechanical and biological factors in the initiation and progression of osteoarthritis. Dr Mündermann is currently a part-time Senior Research Fellow at the University of Otago, New Zealand. Dr Mündermann's technical skills include motion analysis, inverse dynamics, force measurements, electromyography, pressure measurements, MR imaging and Western blots. She has written numerous peer-reviewed journal articles, acted as a reviewer for several journals and has experience in medical writing in a wide range of topics including sport science, rheumatology, orthopedics, biomedical engineering, biomechanics, obesity, rehabilitation, physiotherapy and sport injuries. Dr Mündermann began working with the Edanz Group in 2008.

Ms Garcia obtained an MSc in Bio-Systems Sustainability, specializing in Bioorganic Chemistry, from Hokkaido University, Japan, and is currently a PhD candidate in Food Science at the University of Auckland, New Zealand. Her research is focused on flavor and fragrance chemistry, and she has worked on the characterization of the aroma profiles of flowers and fruits. Her work involves the isolation of volatile and non-volatile compounds, the use of instrumentation (GC-MS, NMR, etc.), and the use of enzymes. She has presented her research at conferences in Japan, New Zealand and China. Ms Garcia also has a broad background in the life sciences, including the isolation and characterization of bioactive compounds and enzymes. She is fluent in English, and speaks and reads Japanese and Spanish. She joined the Edanz Group as an editor in 2011.

Ms Davis has worked in research and development in the areas of biochemistry and molecular biology at several academic institutions in the U.S., Germany, and Denmark. For the last 20 years, she has been employed in biotechnology companies in California where she was involved in heterologous gene expression in yeast and diagnostic assay development as well as laboratory operations. During this time, she was also responsible for editing scientific articles and biotech business documents. She joined the Edanz Group in 2010.

After studies in biochemistry and microbiology at the University of Victoria, Ms Bogh worked as a biomedical researcher with biotechnology companies and university departments. For the last 10 years she has worked for publishers of international, peer-reviewed scientific and technical journals and has edited manuscripts in many disciplines including microbiology, chemistry, biochemistry, molecular biology, and genetics. Ms Bogh is a board-certified Editor in the Life Sciences and recently earned a Postgraduate Certificate in Editing from the Department of Linguistics at Macquarie University. She joined the Edanz Group as an editor in 2012

Dr Aprico's doctoral thesis was "[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters." From 2003 to 2005, Dr Aprico held a post-doctoral position at Arvid Carlsson Institute, Göteborg, Sweden, working with Dr Michael Nilsson, investigating in vitro models of reactive astrogliosis. Since 2005, Dr Aprico has been a university lecturer in pharmacology and physiology, but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.

Mr Arico has been working and studying in the Australian scientific sector for the past several years and has held research positions at internationally recognized organizations such as the Queensland and Garvan Institutes of Medical Research. During this time his research focused on Cancer Immunotherapy and Immunology. Mr Arico has also worked in the private biotechnology sector in the area of Molecular Diagnostics. Mr Arico completed his honors degree in 2006 under the direction of a prominent Professor of Stem Cell Sciences at Monash University researching definitive endoderm differentiation from human embryonic stem cells. His technical skills include: cell culture including human and mouse embryonic stem cells, in vitro cell differentiations using embryonic and adult stem cells, various imaging techniques, cell-based assays, flow cytometry, cell purification techniques, PCR, cloning and retroviral transfections. Mr Arico has a strong interest in tissue engineering technologies and the clinical use of stem cells. He began working as an editor with the Edanz Group in 2011.

Mr Pishief, a barrister and solicitor, is a legal editor and writer of manuscripts for publication in text books, legal bulletins, and online on global legal platforms. His background in both law and science, with his biomedical science study focusing on molecular pathology, specifcally pathology (including histology) of the brain, heart, liver, kidney, bone, blood, and lymphoid system; genetics, including sequencing, bioinformatics and genetic disorders; biomedical laboratory techniques, with a focus on DNA/RNA extraction and isolation, reverse transcription, PCR, and gel electrophoresis; metabolism; immunology; medical microbiology; and physiology (including neurophysiology and neuroimaging). An experienced report and abstract writer, Mr Pishief joined the Edanz Group as an editor in 2011.

Ms Bass is a science writer and editor focused on academic medicine and clinical research. Since 2007, she has served as a grant writer, manuscript editor, and project manager for many UC San Diego laboratories, assisting investigators involved in such diverse fields as hospital policy and quality improvement, radiology, medical physics, nanotechnology, materials science, and genomics. Ms Bass has also edited patient-education and complementary/alternative medicine guidebooks and newsletters for a San Diego-based health insurer. In addition to her academic degrees, in 2004 Ms Bass earned an Advanced Certificate in Technical & Scientific Writing from San Diego State University. Ms Bass joined the Edanz Group as an editor in 2011.

Dr Daniel’s PhD thesis was entitled “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90.” Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one- and two-dimensional gel electrophoresis, assay techniques, Western blot analysis and surface plasmon resonance spectroscopy, and thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with the Edanz Group in 2008.

Mr Frew is presently a Master of Applied Science candidate in the Electrical & Computer Engineering Department of the University of British Columbia, Canada. His research interests include medical image processing and ultrasonic transducer hardware, with applications to medical diagnosis and prostate brachytherapy. Previously, Mr Frew worked at Victoria University of Wellington as a research assistant and spent two and a half years at Fisher & Paykel Healthcare, developing medical devices for the treatment of obstructive sleep apnea. He has experience in a diverse range of topics, including biomedical engineering, microtechnology, electronics and risk management. Mr Frew began working with the Edanz Group in early 2009.